Clinical application of next-generation sequencing in etiological diagnosis of sepsis

Yimin ZHU,Wenhong ZHANG

DOI: https://doi.org/10.3969/j.issn.1673-6184.2018.02.006

2018-01-01

Abstract:Sepsis is a life-threatening infection demanding accurate and fast diagnosis of pathogen for right antibiotics.In current practice,culture-based methods are still the standard approach of etiological diagnosis of sepsis.Practically,these methods have disadvantages including long turnaround time and low sensitivity. Although molecular assays,such as polymerase chain reaction(PCR)-based methods have been established for sepsis,the spectrum of the detection is limited to known pathogens listed on the panel.In the last few years,the next-generation sequencing(NGS)has been constantly improving and stepped into clinical practice,providing a powerful tool with advantages including short turnaround time,full spectrum and semiquantitative analysis.Although NGS has clear advantages compared with culture-based methods,we are facing the following challenges:few acknowledged criteria of sequencing result explanation have been established;the relationship between sequencing results and treatment effects is undetermined;and the drug resistance gene detection is usually with low sensitivity.Besides,large-scale study comparing NGS with traditional etiological diagnosis methods is missing.Thus,NGS still needs high-level evidence to support its clinical application.